Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
interferon alfa-1b (Rebif) (1 trial)
interferon beta-1b (betaseron) (1 trial)
haemophilus influenzae type b conjugate vaccine (HibTITER) (1 trial)
nu300 (1 trial)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)
Communicable Diseases (Phase 2)
Infections (Phase 2)
Multiple Sclerosis (Phase 3)
Multiple Sclerosis, Relapsing-Remitting (Phase 3)
Sclerosis (Phase 3)
Trials (2 total)
Trial APIs (5 total)